We are live on ! Find out more
JNJ icon

Johnson & Johnson

4,107 hedge funds and large institutions have $257B invested in Johnson & Johnson in 2024 Q4 according to their latest regulatory filings, with 471 funds opening new positions, 1,352 increasing their positions, 1,937 reducing their positions, and 177 closing their positions.

New
Increased
Maintained
Reduced
Closed

166% more first-time investments, than exits

New positions opened: 471 | Existing positions closed: 177

25% more call options, than puts

Call options by funds: $2.65B | Put options by funds: $2.11B

6% more funds holding

Funds holding: 3,8844,107 (+223)

0.54% more ownership

Funds ownership: 71.49%72.03% (+0.54%)

8% less capital invested

Capital invested by funds: $278B → $257B (-$20.9B)

24% less funds holding in top 10

Funds holding in top 10: 191146 (-45)

30% less repeat investments, than reductions

Existing positions increased: 1,352 | Existing positions reduced: 1,937

Holders
4,107
Holders Change
+223
Holders Change %
+5.74%
% of All Funds
54.06%
Holding in Top 10
146
Holding in Top 10 Change
-45
Holding in Top 10 Change %
-23.56%
% of All Funds
1.92%
New
471
Increased
1,352
Reduced
1,937
Closed
177
Calls
$2.65B
Puts
$2.11B
Net Calls
+$534M
Net Calls Change
-$67.5M
Name Holding Trade Value Shares
Change
Change in
Stake
OPS
451
Orion Portfolio Solutions
Nebraska
$28.8M -$415K -2,675 -1%
BBVA
452
Banco Bilbao Vizcaya Argentaria
Spain
$28.8M -$3.02M -19,491 -9%
GF
453
Gabelli Funds
New York
$28.3M +$380K +2,450 +1%
MTC
454
McDaniel Terry & Co
Texas
$28.2M +$1.52M +9,780 +5%
JIC
455
Johnson Investment Counsel
Ohio
$28.2M +$36.3K +234 +0.1%
CIA
456
Choate Investment Advisors
Massachusetts
$28.1M -$239K -1,543 -0.8%
AAS
457
Avantax Advisory Services
Texas
$28M -$982K -6,334 -3%
CA
458
Cullinan Associates
Kentucky
$28M -$4.42M -28,547 -13%
ELI
459
Empire Life Investments
Ontario, Canada
$27.9M -$2.47M -15,956 -8%
MPWT
460
MassMutual Private Wealth & Trust
Connecticut
$27.9M -$8.62M -55,601 -22%
DWP
461
Daymark Wealth Partners
Ohio
$27.7M +$1.44M +9,279 +3%
BF
462
BOK Financial
Oklahoma
$27.6M -$362K -2,338 -1%
EWM
463
Evercore Wealth Management
New York
$27.5M -$737K -4,754 -2%
EF
464
Empowered Funds
Pennsylvania
$27.5M +$2.97M +19,136 +11%
NONA
465
Ninety One North America
New York
$27.5M -$1.41M -9,094 -5%
Two Sigma Advisers
466
Two Sigma Advisers
New York
$27.4M +$9.53M +61,493 +48%
NPF
467
Norris Perne & French
Michigan
$27.1M +$18.8K +121 +0.1%
GIBU
468
Gulf International Bank (UK)
United Kingdom
$27M -$325K -2,096 -1%
LOIM
469
Liberty One Investment Management
Illinois
$26.9M +$905K +5,841 +3%
Hudson Bay Capital Management
470
Hudson Bay Capital Management
Connecticut
$26.8M -$57.3M -369,860 -67%
AP
471
Americana Partners
Texas
$26.8M +$16.8M +108,399 +141%
SC
472
Saturna Capital
Washington
$26.4M -$418K -2,696 -1%
OC
473
Oppenheimer & Co
New York
$26.3M +$285K +1,838 +1%
NIM
474
Northeast Investment Management
Massachusetts
$26.1M -$1.34M -8,616 -5%
SIC
475
Salem Investment Counselors
North Carolina
$26M +$77.9K +503 +0.3%

JNJ Hedge Fund Activity: Q4 2024 in Review

4,107 of the 7,597 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q4 2024, worth a combined $257B — down 7.5% from $278B a quarter earlier.

Buyers outnumbered sellers: 471 funds opened new JNJ positions and 177 closed out — a net gain of 294 holders — while 1,352 added to existing stakes and 1,937 trimmed.

The largest buyer was Pinnacle Associates, adding an estimated $729M. The largest seller was T. Rowe Price Associates, cutting an estimated $1.38B.

  • 4,107 institutional investors held Johnson & Johnson (JNJ) as of Q4 2024, up from 3,884 in Q3 2024.
  • Funds reported $257B of Johnson & Johnson stock for Q4 2024, down 7.5% quarter-over-quarter.
  • 471 funds opened new Johnson & Johnson positions in Q4 2024 and 177 closed out, a net change of +294 holders.
  • The largest Johnson & Johnson buyer in Q4 2024 was Pinnacle Associates, an estimated $729M added.
  • The largest Johnson & Johnson seller in Q4 2024 was T. Rowe Price Associates, an estimated $1.38B sold.

Based on aggregated 13F filings for Q4 2024.